ARCHIVES

In Brief: Senate Committee Finishes Work On Renewal Bill, Both Houses (So Far) Leave NCI Authorities Intact

This article is from The Cancer Letter archive.

Vol. 08 No. 21 | May 21, 1982

Download PDF Visit The Full Archive

Related Articles

Revive Comprehensive Program, But Don’t Tie It to Grant Review, Center Executive Agrees

July 29, 1988

ODAC Recommends Iressa Approval As Third-Line Lung Cancer Treatment

September 27, 2002

FDA Approves Abraxane And Alimta for NSCLC

October 26, 2012

NCI Tightens Monitoring, Upgrades Staff Training In Attempts To Improve Management Of Contracts

January 9, 1981

Votrient Trial Meets PFS Endpoint In Epithelial Ovarian Cancer

June 28, 2013

M.D. Anderson Closes Trials following FDA Requests for Data

February 16, 1996